Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers May 27, 2015
Pharmacy Choice - Pharmacy News - May 27, 2015

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
5/27/15 - Dr. Frank Chae at Sky Ridge Medical Center First in Colorado Certified to Offer VBLOC® Vagal Blocking Therapy for the Treatment of Obesity
Frank Chae, Chief of Bariatric Surgery at Sky Ridge Medical Center, is among one of the first physicians in the country certified in implanting the VBLOC ® vagal blocking therapy for the treatment of obesity. On January 14, 2015, EnteroMedics Inc. announced that the U.S. Food and Drug Administration approved VBLOC ® vagal blocking therapy, delive
5/27/15 - FDA Approves New Procedure Giving Baby-boomers Camera-like Vision
SAN ANTONIO, May 27, 2015/ PRNewswire-iReach/-- A new eye procedure recently approved by the Food and Drug Administration corrects the most common vision problem in adults. The inlay is called "Kamra", because it works to restore the eye's zoom capability, just like a camera. The office of Greg Parkhurst, MD, a San Antonio ophthalmologist, is one o
5/27/15 - RegenScientific announces FDA-clearance of its Renu® Gel injectable implant
--RegenScientific announced that it has received FDA- clearance for its Renu ® Gel injectable implant indicated for vocal fold injection augmentation and today the company commenced shipments of this new product to physicians and hospitals in the United States. The company already has FDA- clearance for its Renu ® Voice injectable implant based o
5/27/15 - U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen®
Food and Drug Administration has approved Humalog ® 200 units/mL KwikPen ®, a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog ® to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentr
5/26/15 - Cancer drugs approved quickly but not to patient's benefit: York University researcher
By a News Reporter-Staff News Editor at Cancer Weekly-- TORONTO, Highly priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients, cautions York University Professor Dr. "Drug agencies like the Food and Drug Administration and the European Medicine Agency don't actually look at whether p
5/26/15 - Enrollment Begins in Cellceutix Phase 2 Trial of Brilacidin-OM to Prevent Oral Mucositis in Patients Undergoing Chemoradiation
Cellceutix Corporation, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, and antibiotic applications, is pleased to announce that enrollment has commenced in the Company's Phase 2 clinical trial of Brilacidin-OM for the prevention and treatment of oral mucositis in patients undergoing...

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement